Click for best price
Immunotherapy Drugs Market Size, Share 2023
| Market size in 2022 |
US$ 199340 million
|
Forecast Market size by 2029 |
US$ 392030 million
|
| Growth Rate |
CAGR of 10.1% |
Number of Pages |
68 Pages |
Immunotherapy is a type of cancer treatment that helps your immune system fight cancer. The immune system helps your body fight infections and other diseases. It is made up of white blood cells and organs and tissues of the lymph system.
This report aims to provide a comprehensive presentation of the global market for Immunotherapy Drugs, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Immunotherapy Drugs. This report contains market size and forecasts of Immunotherapy Drugs in global, including the following market information:
Global Immunotherapy Drugs Market Revenue, 2018-2023, 2024-2029, ($ millions)
Global top five companies in 2022 (%)
The global Immunotherapy Drugs market was valued at US$ 199340 million in 2022 and is projected to reach US$ 392030 million by 2029, at a CAGR of 10.1% during the forecast period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
North America is expected to account for largest share in the immunotherapy drugs market, by region in 2018. Asia-Pacific is expected to be the fastest-growing regional segment in the market. The high growth of this segment can primarily be attributed to the low cost of manufacturing and acceptable regulatory scenario in this region.
We surveyed the Immunotherapy Drugs companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Immunotherapy Drugs Market, by Type, 2018-2023, 2024-2029 ($ millions)
Global Immunotherapy Drugs Market Segment Percentages, by Type, 2022 (%)
Monoclonal Antibodies
Adult Vaccines
Checkpoint Inhibitors
Interferons Alpha & Beta
Interleukins
Others
Global Immunotherapy Drugs Market, by Application, 2018-2023, 2024-2029 ($ millions)
Global Immunotherapy Drugs Market Segment Percentages, by Application, 2022 (%)
Cancer
Autoimmune & Inflammatory Diseases
Infectious Diseases
Others
Global Immunotherapy Drugs Market, By Region and Country, 2018-2023, 2024-2029 ($ Millions)
Global Immunotherapy Drugs Market Segment Percentages, By Region and Country, 2022 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Immunotherapy Drugs revenues in global market, 2018-2023 (estimated), ($ millions)
Key companies Immunotherapy Drugs revenues share in global market, 2022 (%)
Further, the report presents profiles of competitors in the market, key players include:
Roche
Merck
Novartis
Johnson & Johnson
Glaxosmithkline
Amgen
Abbvie
Astrazeneca
Bristol-Myers Squibb
ELI Lilly
Outline of Major Chapters:
Chapter 1: Introduces the definition of Immunotherapy Drugs, market overview.
Chapter 2: Global Immunotherapy Drugs market size in revenue.
Chapter 3: Detailed analysis of Immunotherapy Drugs company competitive landscape, revenue and market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6: Sales of Immunotherapy Drugs in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.
Chapter 7: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 8: The main points and conclusions of the report.
| Report Attributes |
Report Details |
| Report Title |
Immunotherapy Drugs Market, Global Outlook and Forecast 2023-2029 |
| Market size in 2022 |
US$ 199340 million
|
| Forecast Market size by 2029 |
US$ 392030 million
|
| Growth Rate |
CAGR of 10.1% |
| Historical Year |
2018 to 2022 (Data from 2010 can be provided as per availability) |
| Base Year |
2022 |
| Forecast Year |
2030 |
| Number of Pages |
68 Pages |
| Customization Available |
Yes, the report can be customized as per your need. |
TABLE OF CONTENTS
1 Introduction to Research & Analysis Reports
1.1 Immunotherapy Drugs Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Immunotherapy Drugs Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Global Immunotherapy Drugs Overall Market Size
2.1 Global Immunotherapy Drugs Market Size: 2022 VS 2029
2.2 Global Immunotherapy Drugs Market Size, Prospects & Forecasts: 2018-2029
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 Company Landscape
3.1 Top Immunotherapy Drugs Players in Global Market
3.2 Top Global Immunotherapy Drugs Companies Ranked by Revenue
3.3 Global Immunotherapy Drugs Revenue by Companies
3.4 Top 3 and Top 5 Immunotherapy Drugs Companies in Global Market, by Revenue in 2022
3.5 Global Companies Immunotherapy Drugs Product Type
3.6 Tier 1, Tier 2 and Tier 3 Immunotherapy Drugs Players in Global Market
3.6.1 List of Global Tier 1 Immunotherapy Drugs Companies
3.6.2 List of Global Tier 2 and Tier 3 Immunotherapy Drugs Companies
4 Market Sights by Product
4.1 Overview
4.1.1 By Type - Global Immunotherapy Drugs Market Size Markets, 2022 & 2029
4.1.2 Monoclonal Antibodies
4.1.3 Adult Vaccines
4.1.4 Checkpoint Inhibitors
4.1.5 Interferons Alpha & Beta
4.1.6 Interleukins
4.1.7 Others
4.2 By Type - Global Immunotherapy Drugs Revenue & Forecasts
4.2.1 By Type - Global Immunotherapy Drugs Revenue, 2018-2023
4.2.2 By Type - Global Immunotherapy Drugs Revenue, 2024-2029
4.2.3 By Type - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
5 Sights by Application
5.1 Overview
5.1.1 By Application - Global Immunotherapy Drugs Market Size, 2022 & 2029
5.1.2 Cancer
5.1.3 Autoimmune & Inflammatory Diseases
5.1.4 Infectious Diseases
5.1.5 Others
5.2 By Application - Global Immunotherapy Drugs Revenue & Forecasts
5.2.1 By Application - Global Immunotherapy Drugs Revenue, 2018-2023
5.2.2 By Application - Global Immunotherapy Drugs Revenue, 2024-2029
5.2.3 By Application - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
6 Sights by Region
6.1 By Region - Global Immunotherapy Drugs Market Size, 2022 & 2029
6.2 By Region - Global Immunotherapy Drugs Revenue & Forecasts
6.2.1 By Region - Global Immunotherapy Drugs Revenue, 2018-2023
6.2.2 By Region - Global Immunotherapy Drugs Revenue, 2024-2029
6.2.3 By Region - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
6.3 North America
6.3.1 By Country - North America Immunotherapy Drugs Revenue, 2018-2029
6.3.2 US Immunotherapy Drugs Market Size, 2018-2029
6.3.3 Canada Immunotherapy Drugs Market Size, 2018-2029
6.3.4 Mexico Immunotherapy Drugs Market Size, 2018-2029
6.4 Europe
6.4.1 By Country - Europe Immunotherapy Drugs Revenue, 2018-2029
6.4.2 Germany Immunotherapy Drugs Market Size, 2018-2029
6.4.3 France Immunotherapy Drugs Market Size, 2018-2029
6.4.4 U.K. Immunotherapy Drugs Market Size, 2018-2029
6.4.5 Italy Immunotherapy Drugs Market Size, 2018-2029
6.4.6 Russia Immunotherapy Drugs Market Size, 2018-2029
6.4.7 Nordic Countries Immunotherapy Drugs Market Size, 2018-2029
6.4.8 Benelux Immunotherapy Drugs Market Size, 2018-2029
6.5 Asia
6.5.1 By Region - Asia Immunotherapy Drugs Revenue, 2018-2029
6.5.2 China Immunotherapy Drugs Market Size, 2018-2029
6.5.3 Japan Immunotherapy Drugs Market Size, 2018-2029
6.5.4 South Korea Immunotherapy Drugs Market Size, 2018-2029
6.5.5 Southeast Asia Immunotherapy Drugs Market Size, 2018-2029
6.5.6 India Immunotherapy Drugs Market Size, 2018-2029
6.6 South America
6.6.1 By Country - South America Immunotherapy Drugs Revenue, 2018-2029
6.6.2 Brazil Immunotherapy Drugs Market Size, 2018-2029
6.6.3 Argentina Immunotherapy Drugs Market Size, 2018-2029
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Immunotherapy Drugs Revenue, 2018-2029
6.7.2 Turkey Immunotherapy Drugs Market Size, 2018-2029
6.7.3 Israel Immunotherapy Drugs Market Size, 2018-2029
6.7.4 Saudi Arabia Immunotherapy Drugs Market Size, 2018-2029
6.7.5 UAE Immunotherapy Drugs Market Size, 2018-2029
7 Immunotherapy Drugs Companies Profiles
7.1 Roche
7.1.1 Roche Company Summary
7.1.2 Roche Business Overview
7.1.3 Roche Immunotherapy Drugs Major Product Offerings
7.1.4 Roche Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.1.5 Roche Key News & Latest Developments
7.2 Merck
7.2.1 Merck Company Summary
7.2.2 Merck Business Overview
7.2.3 Merck Immunotherapy Drugs Major Product Offerings
7.2.4 Merck Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.2.5 Merck Key News & Latest Developments
7.3 Novartis
7.3.1 Novartis Company Summary
7.3.2 Novartis Business Overview
7.3.3 Novartis Immunotherapy Drugs Major Product Offerings
7.3.4 Novartis Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.3.5 Novartis Key News & Latest Developments
7.4 Johnson & Johnson
7.4.1 Johnson & Johnson Company Summary
7.4.2 Johnson & Johnson Business Overview
7.4.3 Johnson & Johnson Immunotherapy Drugs Major Product Offerings
7.4.4 Johnson & Johnson Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.4.5 Johnson & Johnson Key News & Latest Developments
7.5 Glaxosmithkline
7.5.1 Glaxosmithkline Company Summary
7.5.2 Glaxosmithkline Business Overview
7.5.3 Glaxosmithkline Immunotherapy Drugs Major Product Offerings
7.5.4 Glaxosmithkline Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.5.5 Glaxosmithkline Key News & Latest Developments
7.6 Amgen
7.6.1 Amgen Company Summary
7.6.2 Amgen Business Overview
7.6.3 Amgen Immunotherapy Drugs Major Product Offerings
7.6.4 Amgen Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.6.5 Amgen Key News & Latest Developments
7.7 Abbvie
7.7.1 Abbvie Company Summary
7.7.2 Abbvie Business Overview
7.7.3 Abbvie Immunotherapy Drugs Major Product Offerings
7.7.4 Abbvie Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.7.5 Abbvie Key News & Latest Developments
7.8 Astrazeneca
7.8.1 Astrazeneca Company Summary
7.8.2 Astrazeneca Business Overview
7.8.3 Astrazeneca Immunotherapy Drugs Major Product Offerings
7.8.4 Astrazeneca Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.8.5 Astrazeneca Key News & Latest Developments
7.9 Bristol-Myers Squibb
7.9.1 Bristol-Myers Squibb Company Summary
7.9.2 Bristol-Myers Squibb Business Overview
7.9.3 Bristol-Myers Squibb Immunotherapy Drugs Major Product Offerings
7.9.4 Bristol-Myers Squibb Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.9.5 Bristol-Myers Squibb Key News & Latest Developments
7.10 ELI Lilly
7.10.1 ELI Lilly Company Summary
7.10.2 ELI Lilly Business Overview
7.10.3 ELI Lilly Immunotherapy Drugs Major Product Offerings
7.10.4 ELI Lilly Immunotherapy Drugs Revenue in Global Market (2018-2023)
7.10.5 ELI Lilly Key News & Latest Developments
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES & FIGURES
List of Tables
Table 1. Immunotherapy Drugs Market Opportunities & Trends in Global Market
Table 2. Immunotherapy Drugs Market Drivers in Global Market
Table 3. Immunotherapy Drugs Market Restraints in Global Market
Table 4. Key Players of Immunotherapy Drugs in Global Market
Table 5. Top Immunotherapy Drugs Players in Global Market, Ranking by Revenue (2022)
Table 6. Global Immunotherapy Drugs Revenue by Companies, (US$, Mn), 2018-2023
Table 7. Global Immunotherapy Drugs Revenue Share by Companies, 2018-2023
Table 8. Global Companies Immunotherapy Drugs Product Type
Table 9. List of Global Tier 1 Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Immunotherapy Drugs Companies, Revenue (US$, Mn) in 2022 and Market Share
Table 11. By Type ? Global Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 12. By Type - Immunotherapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 13. By Type - Immunotherapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 14. By Application ? Global Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 15. By Application - Immunotherapy Drugs Revenue in Global (US$, Mn), 2018-2023
Table 16. By Application - Immunotherapy Drugs Revenue in Global (US$, Mn), 2024-2029
Table 17. By Region ? Global Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Table 18. By Region - Global Immunotherapy Drugs Revenue (US$, Mn), 2018-2023
Table 19. By Region - Global Immunotherapy Drugs Revenue (US$, Mn), 2024-2029
Table 20. By Country - North America Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 21. By Country - North America Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 22. By Country - Europe Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 23. By Country - Europe Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 24. By Region - Asia Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 25. By Region - Asia Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 26. By Country - South America Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 27. By Country - South America Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 28. By Country - Middle East & Africa Immunotherapy Drugs Revenue, (US$, Mn), 2018-2023
Table 29. By Country - Middle East & Africa Immunotherapy Drugs Revenue, (US$, Mn), 2024-2029
Table 30. Roche Company Summary
Table 31. Roche Immunotherapy Drugs Product Offerings
Table 32. Roche Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 33. Roche Key News & Latest Developments
Table 34. Merck Company Summary
Table 35. Merck Immunotherapy Drugs Product Offerings
Table 36. Merck Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 37. Merck Key News & Latest Developments
Table 38. Novartis Company Summary
Table 39. Novartis Immunotherapy Drugs Product Offerings
Table 40. Novartis Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 41. Novartis Key News & Latest Developments
Table 42. Johnson & Johnson Company Summary
Table 43. Johnson & Johnson Immunotherapy Drugs Product Offerings
Table 44. Johnson & Johnson Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 45. Johnson & Johnson Key News & Latest Developments
Table 46. Glaxosmithkline Company Summary
Table 47. Glaxosmithkline Immunotherapy Drugs Product Offerings
Table 48. Glaxosmithkline Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 49. Glaxosmithkline Key News & Latest Developments
Table 50. Amgen Company Summary
Table 51. Amgen Immunotherapy Drugs Product Offerings
Table 52. Amgen Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 53. Amgen Key News & Latest Developments
Table 54. Abbvie Company Summary
Table 55. Abbvie Immunotherapy Drugs Product Offerings
Table 56. Abbvie Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 57. Abbvie Key News & Latest Developments
Table 58. Astrazeneca Company Summary
Table 59. Astrazeneca Immunotherapy Drugs Product Offerings
Table 60. Astrazeneca Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 61. Astrazeneca Key News & Latest Developments
Table 62. Bristol-Myers Squibb Company Summary
Table 63. Bristol-Myers Squibb Immunotherapy Drugs Product Offerings
Table 64. Bristol-Myers Squibb Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 65. Bristol-Myers Squibb Key News & Latest Developments
Table 66. ELI Lilly Company Summary
Table 67. ELI Lilly Immunotherapy Drugs Product Offerings
Table 68. ELI Lilly Immunotherapy Drugs Revenue (US$, Mn) & (2018-2023)
Table 69. ELI Lilly Key News & Latest Developments
List of Figures
Figure 1. Immunotherapy Drugs Segment by Type in 2022
Figure 2. Immunotherapy Drugs Segment by Application in 2022
Figure 3. Global Immunotherapy Drugs Market Overview: 2022
Figure 4. Key Caveats
Figure 5. Global Immunotherapy Drugs Market Size: 2022 VS 2029 (US$, Mn)
Figure 6. Global Immunotherapy Drugs Revenue, 2018-2029 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Immunotherapy Drugs Revenue in 2022
Figure 8. By Type - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 9. By Application - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 10. By Type - Global Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 11. By Type - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 12. By Application - Global Immunotherapy Drugs Revenue, (US$, Mn), 2022 & 2029
Figure 13. By Application - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 14. By Region - Global Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 15. By Country - North America Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 16. US Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 17. Canada Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 18. Mexico Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 19. By Country - Europe Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 20. Germany Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 21. France Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 22. U.K. Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 23. Italy Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 24. Russia Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 25. Nordic Countries Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 26. Benelux Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 27. By Region - Asia Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 28. China Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 29. Japan Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 30. South Korea Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 31. Southeast Asia Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 32. India Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 33. By Country - South America Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 34. Brazil Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 35. Argentina Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 36. By Country - Middle East & Africa Immunotherapy Drugs Revenue Market Share, 2018-2029
Figure 37. Turkey Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 38. Israel Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 39. Saudi Arabia Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 40. UAE Immunotherapy Drugs Revenue, (US$, Mn), 2018-2029
Figure 41. Roche Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 42. Merck Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 43. Novartis Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 44. Johnson & Johnson Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 45. Glaxosmithkline Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 46. Amgen Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 47. Abbvie Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 48. Astrazeneca Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 49. Bristol-Myers Squibb Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
Figure 50. ELI Lilly Immunotherapy Drugs Revenue Year Over Year Growth (US$, Mn) & (2018-2023)
